Cargando…
Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Vet...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879921/ https://www.ncbi.nlm.nih.gov/pubmed/36712473 http://dx.doi.org/10.1017/ash.2022.348 |
_version_ | 1784878796568002560 |
---|---|
author | Fitzpatrick, Margaret A. Wirth, Marissa Nguyen, Jimmy Suda, Katie J. Weaver, Frances M. Burns, Stephen Collins, Eileen Safdar, Nasia Patel, Ursula Evans, Charlesnika T. |
author_facet | Fitzpatrick, Margaret A. Wirth, Marissa Nguyen, Jimmy Suda, Katie J. Weaver, Frances M. Burns, Stephen Collins, Eileen Safdar, Nasia Patel, Ursula Evans, Charlesnika T. |
author_sort | Fitzpatrick, Margaret A. |
collection | PubMed |
description | OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Veterans’ Affairs hospitals. PARTICIPANTS: The study included veterans with NB due to spinal cord injury or disorder (SCI/D), multiple sclerosis (MS), or Parkinson’s disease (PD) hospitalized between January 1, 2017, and December 31, 2018, with diagnosis of ASB or UTI. INTERVENTIONS: In a medical record review, we classified ASB and UTI diagnoses and treatments as appropriate or inappropriate based on national guidelines. MAIN OUTCOME MEASURES: Frequencies of Clostridioides difficile infection, acute kidney injury, 90-day hospital readmission, postculture length-of-stay (LOS), and multidrug-resistant organisms in subsequent urine cultures were compared between those who received appropriate and inappropriate management. RESULTS: We included 170 encounters with ASB (30%) or UTI (70%) diagnoses occurring for 166 patients. Overall, 86.1% patients were male, 47.6% had SCI/D and 77.6% used bladder catheters. All ASB encounters had appropriate diagnoses, and 96.1% had appropriate treatment. In contrast, 37 UTI encounters (31.1%) had inappropriate diagnoses and 61 (51.3%) had inappropriate treatment, including 30 encounters with true ASB. Among patients with SCI/D or MS, appropriate ASB or UTI diagnosis was associated with a longer postculture LOS (median, 14 vs 7.5 days; P = .02). We did not detect any significant associations between appropriate versus inappropriate diagnosis and treatment and other outcomes. CONCLUSIONS: Almost one-third of UTI diagnoses and half of treatments in hospitalized patients with NB are inappropriate. Opportunities exist to improve ASB and UTI management in patients with NB to minimize inappropriate antibiotic use. |
format | Online Article Text |
id | pubmed-9879921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98799212023-01-28 Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder Fitzpatrick, Margaret A. Wirth, Marissa Nguyen, Jimmy Suda, Katie J. Weaver, Frances M. Burns, Stephen Collins, Eileen Safdar, Nasia Patel, Ursula Evans, Charlesnika T. Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Veterans’ Affairs hospitals. PARTICIPANTS: The study included veterans with NB due to spinal cord injury or disorder (SCI/D), multiple sclerosis (MS), or Parkinson’s disease (PD) hospitalized between January 1, 2017, and December 31, 2018, with diagnosis of ASB or UTI. INTERVENTIONS: In a medical record review, we classified ASB and UTI diagnoses and treatments as appropriate or inappropriate based on national guidelines. MAIN OUTCOME MEASURES: Frequencies of Clostridioides difficile infection, acute kidney injury, 90-day hospital readmission, postculture length-of-stay (LOS), and multidrug-resistant organisms in subsequent urine cultures were compared between those who received appropriate and inappropriate management. RESULTS: We included 170 encounters with ASB (30%) or UTI (70%) diagnoses occurring for 166 patients. Overall, 86.1% patients were male, 47.6% had SCI/D and 77.6% used bladder catheters. All ASB encounters had appropriate diagnoses, and 96.1% had appropriate treatment. In contrast, 37 UTI encounters (31.1%) had inappropriate diagnoses and 61 (51.3%) had inappropriate treatment, including 30 encounters with true ASB. Among patients with SCI/D or MS, appropriate ASB or UTI diagnosis was associated with a longer postculture LOS (median, 14 vs 7.5 days; P = .02). We did not detect any significant associations between appropriate versus inappropriate diagnosis and treatment and other outcomes. CONCLUSIONS: Almost one-third of UTI diagnoses and half of treatments in hospitalized patients with NB are inappropriate. Opportunities exist to improve ASB and UTI management in patients with NB to minimize inappropriate antibiotic use. Cambridge University Press 2022-12-09 /pmc/articles/PMC9879921/ /pubmed/36712473 http://dx.doi.org/10.1017/ash.2022.348 Text en © The Author(s) 2022 This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Fitzpatrick, Margaret A. Wirth, Marissa Nguyen, Jimmy Suda, Katie J. Weaver, Frances M. Burns, Stephen Collins, Eileen Safdar, Nasia Patel, Ursula Evans, Charlesnika T. Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title | Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title_full | Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title_fullStr | Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title_full_unstemmed | Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title_short | Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
title_sort | clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879921/ https://www.ncbi.nlm.nih.gov/pubmed/36712473 http://dx.doi.org/10.1017/ash.2022.348 |
work_keys_str_mv | AT fitzpatrickmargareta clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT wirthmarissa clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT nguyenjimmy clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT sudakatiej clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT weaverfrancesm clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT burnsstephen clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT collinseileen clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT safdarnasia clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT patelursula clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder AT evanscharlesnikat clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder |